|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
« Previous
Saturday, July 25
Natalizumab associated with pro-inflammatory T cells
by
All About MS
on Sat 25 Jul 2009 12:00 AM CST
Natalizumab is an antibody directed against integrin alpha4 that reduces disease activity in patients with multiple sclerosis (MS) by blocking migration of T and B cells into the Central Nervouse System (CNS). The goal of this study was more »
Friday, July 10
phase III trial of Mylinax (oral cladribine)
by
All About MS
on Fri 10 Jul 2009 04:30 PM CST
Over the two-year period of the study, 80% of the low dose regimen Cladribine arm and 79% of the high-dose regimen arm experienced no clinical relapse, compared with 61% of the more »
Drug Trial - Female Stress Urinary Incontinence
by
All About MS
on Fri 10 Jul 2009 04:18 PM CST
Over 11 million women in the United States suffer from stress urinary incontinence (SUI), the involuntary leakage of urine during routine physical activities such as laughing, coughing, exercising, or sneezing. SUI affects women more »
Monday, July 6
U.S. Study Will Test Vitamin D, Fish Oil
by
All About MS
on Mon 06 Jul 2009 12:00 AM CST
Two of the most popular and promising dietary supplements -- vitamin D and fish oil -- will be tested in a large, government-sponsored study to see whether either nutrient can lower a healthy person's risk of getting cancer more »
Sunday, July 5
Oral Laquinimod Phase III MS Clinical Trial
by
All About MS
on Sun 05 Jul 2009 11:02 AM CST
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced completion of patient enrollment for the second pivotal Phase III clinical trial, BRAVO, evaluating the novel, oral once-daily immunomodulating more »
Saturday, July 4
Study - Spasticity
by
All About MS
on Sat 04 Jul 2009 12:00 AM CST
This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires more »
Friday, July 3
Study - Restless Legs
by
All About MS
on Fri 03 Jul 2009 10:53 AM CST
Discomfort or pain in your legs which worsens at night or when resting
A strong urge to move your legs for relief
Itching, pulling, creepy-crawly, tugging, or gnawing more »
Sunday, June 21
Clinical Study – Volunteers Needed 2
by
All About MS
on Sun 21 Jun 2009 01:00 AM CST
This is an early phase study designed to test the safety of a compound. This is one of the steps necessary before conducting a large clinical trial to determine if the agent ONO-4641 is effective in MS.
Main Eligibility R more »
Saturday, June 20
Clinical Study – Volunteers Needed
by
All About MS
on Sat 20 Jun 2009 09:32 AM CST
A Randomized, Double-blind, Placebo-Controlled, Escalating-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS-0777,
Administered more »
Friday, June 19
Clinical Trial - Spasticity
by
All About MS
on Fri 19 Jun 2009 08:27 AM CST
This research study will evaluate a treatment for moderate to severe spasticity associated with MS. All patients must have been on baclofen for at least four weeks prior to first visit. This study requires five visits over more »
Monday, April 27
Study - Restless Leg Syndrome
by
All About MS
on Mon 27 Apr 2009 12:00 AM CST
Make $250.00 - RLS is a disorder of the nervous system affecting movement of the legs, usually interfering with sleep. If you are suffering from this disorder, you may wish to consider a clinical research study of a more »
Saturday, April 18
MS Therapies in the Pipeline
by
All About MS
on Sat 18 Apr 2009 09:50 AM CST
It is a time of exciting evolution and expansion in MS research, and there are many potentially life-changing MS therapies that are making their way through the medical pipeline. The Rocky Mountain MS Center, along with other organizations, is committed more »
Wednesday, April 15
MAESTRO-03 trial of Dirucotide in patients with SPMS
by
All About MS
on Wed 15 Apr 2009 08:21 AM CST
BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) for the Company's U.S. pivotal phase III MAESTRO-03 trial of Dirucotide in more »
Wednesday, April 8
Stem Cell Research Clinical Trial Information
by
All About MS
on Wed 08 Apr 2009 09:44 AM CST
The purpose of this study is to determine the effectiveness of a new treatment for multiple sclerosis (MS), a serious disease in which the immune system attacks the brain and spinal cord. MS can be progressive and severe and lead to significant disability. The study more »
Friday, April 3
Drug Trial BVA-101, Positive Efficacy Results
by
All About MS
on Fri 03 Apr 2009 05:00 AM CST
Biovista Inc. today announced that BVA-101, its drug targeting Multiple Sclerosis (MS), has shown significant positive results in the MOG-induced Experimental Allergic Encephalomyelitis (EAE) murine model of MS. BVA-101, an existing drug that Biovista repositioned more »
|
||
